186 related articles for article (PubMed ID: 16083330)
1. Emerging drugs for the treatment of myelodysplastic syndrome.
Nivatpumin PJ; Gore SD
Expert Opin Emerg Drugs; 2005 Aug; 10(3):569-90. PubMed ID: 16083330
[TBL] [Abstract][Full Text] [Related]
2. Treating myelodysplastic syndromes.
Ryan C; McCann S
IDrugs; 2005 Apr; 8(4):320-6. PubMed ID: 15800807
[TBL] [Abstract][Full Text] [Related]
3. Emerging drugs for adult acute lymphoblastic leukaemia.
Thomas X
Expert Opin Emerg Drugs; 2005 Aug; 10(3):591-617. PubMed ID: 16083331
[TBL] [Abstract][Full Text] [Related]
4. New agents in myelodysplastic syndromes.
Jabbour EJ; Giles FJ
Curr Hematol Rep; 2005 May; 4(3):191-9. PubMed ID: 15865871
[TBL] [Abstract][Full Text] [Related]
5. An update on the treatment of myelodysplastic syndromes.
Kurtin SE; Demakos EP
Clin J Oncol Nurs; 2010 Jun; 14(3):E29-44. PubMed ID: 20529786
[TBL] [Abstract][Full Text] [Related]
6. Novel agents for the management of myelodysplastic syndromes.
Meletis J; Viniou N; Terpos E
Med Sci Monit; 2006 Sep; 12(9):RA194-206. PubMed ID: 16940944
[TBL] [Abstract][Full Text] [Related]
7. Update on the therapy for myelodysplastic syndrome.
Kasner MT; Luger SM
Am J Hematol; 2009 Mar; 84(3):177-86. PubMed ID: 19195035
[TBL] [Abstract][Full Text] [Related]
8. 5-azacitidine: An alternative treatment of myelodysplastic syndromes in patient with refractory response to hematopoietic growth factor, a case report and review of literatures.
Suwanawiboon B; Sumida KN
Hawaii Med J; 2004 Jan; 63(1):14-6, 25. PubMed ID: 15011897
[TBL] [Abstract][Full Text] [Related]
9. Emerging drugs in cutaneous T-cell lymphomas.
Dummer R
Expert Opin Emerg Drugs; 2005 May; 10(2):381-92. PubMed ID: 15934873
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
11. Novel therapies for myelodysplastic syndromes.
Faderl S; Kantarjian HM
Cancer; 2004 Jul; 101(2):226-41. PubMed ID: 15241818
[TBL] [Abstract][Full Text] [Related]
12. Farnesyltransferase inhibitors and their potential role in therapy for myelodysplastic syndromes and acute myeloid leukaemia.
Braun T; Fenaux P
Br J Haematol; 2008 May; 141(5):576-86. PubMed ID: 18410457
[TBL] [Abstract][Full Text] [Related]
13. DNA methyltransferase inhibitors in myelodysplastic syndrome.
Silverman LR
Best Pract Res Clin Haematol; 2004 Dec; 17(4):585-94. PubMed ID: 15494296
[TBL] [Abstract][Full Text] [Related]
14. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
Oliansky DM; Antin JH; Bennett JM; Deeg HJ; Engelhardt C; Heptinstall KV; de Lima M; Gore SD; Potts RG; Silverman LR; Jones RB; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2009 Feb; 15(2):137-72. PubMed ID: 19167676
[TBL] [Abstract][Full Text] [Related]
15. New agents in myelodysplastic syndromes.
Jabbour E; Giles FJ
Curr Hematol Malig Rep; 2006 Mar; 1(1):25-33. PubMed ID: 20425328
[TBL] [Abstract][Full Text] [Related]
16. The evolution of hematopoietic SCT in myelodysplastic syndrome.
Kindwall-Keller T; Isola LM
Bone Marrow Transplant; 2009 Apr; 43(8):597-609. PubMed ID: 19252532
[TBL] [Abstract][Full Text] [Related]
17. Current therapeutic approaches for patients with myelodysplastic syndromes.
Greenberg PL
Br J Haematol; 2010 Jul; 150(2):131-43. PubMed ID: 20507314
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic transplantation for myelodysplastic syndrome (MDS).
Ingram W; Lim ZY; Mufti GJ
Blood Rev; 2007 Mar; 21(2):61-71. PubMed ID: 16759774
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of signaling in myelodysplastic syndrome.
Gore SD
Best Pract Res Clin Haematol; 2004 Dec; 17(4):613-22. PubMed ID: 15494298
[TBL] [Abstract][Full Text] [Related]
20. Myelodysplastic syndrome in children and adolescents.
Niemeyer CM; Baumann I
Semin Hematol; 2008 Jan; 45(1):60-70. PubMed ID: 18179970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
